Research Wire

Researchers at WashU Medicine conducted a study to understand the genetic factors behind a pediatric brain tumor. Their findings could lead to new targeted therapies.

A new analysis, led by WashU Medicine researchers and published in Cell Genomics, examines how certain proteins in human cells are implicated in both cancer and neurodevelopmental disorders, but behave differently, complicating potential interventions.

Elizabeth Pollina, an assistant professor of developmental biology at WashU Medicine, has received the 2025 MIND Prize from the Pershing Square Foundation.

Researchers at the McKelvey School of Engineering will investigate the effect of estrogen on thoracic aortic aneurysm development and develop patient-specific biomarkers to manage the disease.

Megan Tierney Baldridge, MD, PhD, an associate professor in the Department of Medicine at WashU Medicine, received a $100,000 grant to explore the interactions between the viruses that infect bacteria, known as bacteriophages, and human intestinal epithelial cells.

Researchers at WashU Medicine have harnessed the internal circadian clock of the body to deliver medication for an inflammatory illness precisely when it was most needed.

Microscopy researchers at Washington University developed a new method to improve precision in molecular imaging.

Refugees resettled in the U.S. often define success in ways that go far beyond economic self-sufficiency, according to a new study co-authored by WashU researchers. The study challenges long-held assumptions about what makes resettlement successful in the U.S.

A clinical trial led by Richard S. Hotchkiss, MD, a professor of anesthesiology at WashU Medicine, has found that treating critically ill COVID-19 patients with an immune-boosting protein reduces life-threatening secondary infections, a major cause of death in such patients.

The National Institutes of Health (NIH) is supporting a WashU Medicine effort to track neuroinflammation in the brains of patients with Parkinson’s disease.